Developer docs
API playgroundTry for free, no card

Search company profiles

Bioeureka

Full company profile

uuid0002dvz

Namestring
Bioeureka
Legal namestring
TECHNOLOGIE BIOEUREKA INC.
Websiteurl
bioeureka.com
Company typeenum
Private
Founded yearint
2022
Descriptiontext

Bioeureka (legal name: TECHNOLOGIE BIOEUREKA INC.) is a Canadian diagnostics technology company founded in 2022 and headquartered in Montreal, with R&D operations in Ottawa. The company has developed an integrated platform that combines AI software (AIMO) with a proprietary consumable culture medium (MicroSelect) to automate microbiological pathogen detection for food safety, clinical diagnostics, environmental testing, and academic research laboratories. AIMO is a computer vision and deep learning platform trained on millions of annotated pathogen images (covering E. coli, Salmonella, Listeria, Campylobacter, yeasts, and moulds) that identifies microorganisms from microscopic images within seconds after incubation, reportedly achieving accuracy above 95% and producing audit-ready compliance reports with confidence scores. MicroSelect is a tri-compartment 100mm Petri dish combining TSA with 5% sheep blood, MacConkey agar, and Mannitol Salt Agar on a single plate, engineered to shorten culture time and produce images optimized for the AI analysis.

The company monetizes through a hybrid model: SaaS-style subscriptions and pay-per-test pricing ($4.99 per test, compared to $43-72 at reference labs), consumable sales of MicroSelect plates, and a freemium acquisition funnel offering 500 free analyses per month plus a 30-day free trial. Distribution combines a self-serve web portal (app.bioeureka.com) with direct enterprise sales, plus a Canadian lab-services channel for SIAL/SFCA compliance testing. Go-to-market is product-led for SMB and individual users and sales-led for enterprise and mid-market accounts, supported by trade show presence (SIAL Canada), an ROI calculator, and white-paper content marketing.

Bioeureka is private, has no disclosed revenue, and has raised approximately $1.75M in cumulative funding across five rounds from 2022 to 2024. The platform only began commercial operations in April 2025. Key strategic partners include Mila, IVADO, University of Ottawa, NRC (CNRC), Centech, Chrono Innovation, and BioLab Ottawa. The company has been recognized as an elite Canadian medtech company by AdvaMed and has received multiple regional innovation awards.

Short descriptiontext

Bioeureka is a Montreal-based AI diagnostics company that provides food safety, clinical, and environmental laboratories with an AI-powered pathogen identification platform (AIMO) paired with a proprietary culture medium (MicroSelect), reducing per-test costs from $43-72 to $4.99 and turnaround times by 85%.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersMontréal, Canada
HQ citystring
Montréal
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
microbial pathogen identification, AI image recognition, food safety testing, clinical diagnostics AI, microbiological consumables
Industry2 codes
PRIMARYHLAAAJAD
Process Analytical Technology (PAT) & In-Line/At-Line Analytics (spectroscopy, sensors, monitoring)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
SECONDARYHLAGADAH
Cell-Based & Potency Assays (Bioassays)
NAICS code2 codes
  • Analytical Laboratory Instrument Manufacturing334516
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • In Vitro & In Vivo Diagnostic Substances2835
  • Laboratory Analytical Instruments3826
Product category
AI-driven microbiological diagnostics
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1SaaS Subscriptions (AIMO Platform)
TypeSubscription Recurring
Description

Cloud-based AI platform subscription for pathogen identification and analysis. Users pay per test or through subscription plans based on usage volume. The platform generates audit-ready reports and confidence scores.

bioeureka.com
2Consumables (MicroSelect)
TypeHardware Sales
Description

Proprietary culture medium plates sold as consumables. Designed to work exclusively with the AIMO platform, creating a hardware-software ecosystem. A laboratory analyzing 100 isolates per month can save more than $7,500 per year in consumables.

bioeureka.com
3Freemium/Trial Revenue Conversion
TypeFreemium
Description

500 free analyses per month for new users, with 30-day free trial available. Conversion from free tier to paid subscriptions represents the primary customer acquisition revenue flow.

bioeureka.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure, Supply Chain
Pricing details3 tiers
1Freemium - 500 free analyses per month
ModelFreemiumBilling cadenceMonthly
Notes

New users receive 500 free test credits upon activation to explore the platform and evaluate it alongside existing procedures. No commitment required.

bioeureka.com
2Pay-per-test model
ModelUsage-basedBilling cadencePay-as-you-go
Notes

$4.99 per test with Bioeureka compared to $43-72 for reference labs and $15-25 for manual in-house methods. ROI calculator available on website showing significant savings.

bioeureka.com
330-day free trial
ModelFreemiumBilling cadenceMonthly
Notes

30-day free trial available with no commitment. Contact sales for personalized demo and custom pricing for enterprise volume requirements.

bioeureka.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 2 records shown
1AIMO
Description

AI platform for microbiological image recognition that identifies pathogens and microorganisms in seconds after incubation with accuracy above 95%, generating audit-ready compliance reports with confidence scores.

bioeureka.com
+1 more record
Core offering1 text field

Bioeureka provides an AI-powered pathogen identification platform that combines the AIMO cloud software with the MicroSelect proprietary culture medium to automate microbiological detection. The solution analyzes microscopic images of bacterial colonies within minutes of incubation, delivering 95%+ accuracy, audit-ready compliance reports, and per-test costs of $4.99 versus $43–$72 for reference labs, targeting food safety, clinical diagnostics, environmental, and academic laboratories.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • Reduces cost per test from $43-72 to $4.99 (90%+ savings)
+6 more records
Product overview1 text field

Bioeureka offers a unified platform combining AI software (AIMO) with a proprietary consumable (MicroSelect) to automate microbiological detection for food safety and applied microbiology. The platform is designed to integrate seamlessly into existing laboratory workflows, requiring only a standard microscope, camera, and computer. AIMO provides AI-powered pathogen identification from microscopic images, while MicroSelect serves as the optimized culture medium that enables faster, more reliable microbial selection and better imaging results for the AI analysis.

Product and service2 records
1AIMO
CategoryAI pathogen identification SaaS platform
Description

AI-powered cloud platform dedicated to microbiological image recognition; trained on millions of images of pathogens and microorganisms, identifies colonies within seconds after incubation with accuracy above 95% and automatically generates audit-ready reports with confidence scores for food safety, clinical diagnostics, environmental testing, and academic laboratories.

2MicroSelect
CategoryMicrobiological culture medium consumable
Description

Optimized tri-compartment Petri dish (100mm) combining TSA with 5% sheep blood, MacConkey agar, and Mannitol Salt Agar on a single plate; designed to work with AIMO to shorten culture time and improve image quality for AI analysis. Storage at 2–8°C with a 6-month shelf life.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership14 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic R&D partnership for development and validation of AI-powered pathogen detection technology. The university provides scientific expertise and laboratory facilities for testing and refining the platform.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration with Mila for AI model development and deep learning expertise for pathogen identification algorithms.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership with IVADO for data science expertise and research collaboration in AI for microbiology.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Selected for Centech Propulsion accelerator program, providing mentorship, resources, and validation support for the startup.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership for innovation and development activities in Montreal, contributing to platform development and testing.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration with NRC for industrial technology advisory and potential regulatory pathway support.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Ottawa-based innovation support organization providing resources and connections for company growth.

8Économie et Innovation Québec
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Quebec government organization supporting innovation and economic development in the province.

bioeureka.com
9BioLab Ottawa
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Initial testing and validation of the Bioeureka platform conducted at BioLab Ottawa facilities.

bioeureka.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Ottawa-based innovation lab contributing to technology development and validation.

11AXEO (programme Élévation)
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Business development support through the AXEO Elevation program.

bioeureka.com
Strategic tierMinorTypeOthers
Description

Quebec law firm providing legal advisory services.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Technology partner contributing to platform development.

14INNOVACITÉ
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Innovation ecosystem partner supporting company growth.

bioeureka.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Global leader in microbiological diagnostics and industrial microbiology. Directly comparable as it sells automated pathogen identification platforms and culture media into the same food safety, clinical and industrial testing customers that Bioeureka targets.

TypeDirect peer
Description

Specialist in rapid food safety and environmental pathogen testing, including ATP and molecular diagnostics. Closely overlaps with Bioeureka's food-safety testing focus and serves similar food processing and QA laboratories.

TypeBroad incumbent
Description

Established food safety and animal safety diagnostics provider offering pathogen detection kits, instruments and consumables. Comparable as a broad incumbent addressing the same food-safety testing use cases with a wider product portfolio.

TypeBroad incumbent
Description

Major life sciences and diagnostics company with a large microbiology and clinical diagnostics franchise (BD MAX, BD Phoenix). Overlaps with Bioeureka in automated microbial identification and consumable culture media used in clinical labs.

TypeDirect peer
Description

Life science and clinical diagnostics company with strong microbiology and food safety testing offerings. Directly comparable as it sells both laboratory instruments and consumables used for pathogen identification workflows.

TypeBroad incumbent
Description

Global life sciences tools leader with microbiology instruments, consumables and analytical software. Broad incumbent providing competing laboratory analytical instruments and services for pathogen testing.

TypeEmerging player
Description

Emerging player in rapid phenotypic antimicrobial susceptibility testing and microbial identification. Comparable as an early-stage company applying novel sensing/automation to accelerate microbiology lab workflows.

TypeEmerging player
Description

Developed molecular pathogen detection assays for food safety; comparable as a focused player in rapid food pathogen testing that ultimately highlighted both the opportunity and consolidation risk in this space.

TypeRegional player
Description

Food testing and certification services network with strong global but regionally anchored operations. Comparable as a service-side peer providing outsourced microbiological testing that Bioeureka's in-house platform aims to disintermediate.

TypeEmerging player
Description

Applies AI and computer vision to automated culture-plate reading in microbiology labs. Highly comparable as a niche AI-for-microbiology peer addressing the same workflow of automating pathogen identification from plate images.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors7 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Bioeureka

AI-driven microbiological diagnosticsbioeureka.com

Bioeureka is a Montreal-based AI diagnostics company that provides food safety, clinical, and environmental laboratories with an AI-powered pathogen identification platform (AIMO) paired with a proprietary culture medium (MicroSelect), reducing per-test costs from $43-72 to $4.99 and turnaround times by 85%.

What Bioeureka does

Bioeureka (legal name: TECHNOLOGIE BIOEUREKA INC.) is a Canadian diagnostics technology company founded in 2022 and headquartered in Montreal, with R&D operations in Ottawa. The company has developed an integrated platform that combines AI software (AIMO) with a proprietary consumable culture medium (MicroSelect) to automate microbiological pathogen detection for food safety, clinical diagnostics, environmental testing, and academic research laboratories. AIMO is a computer vision and deep learning platform trained on millions of annotated pathogen images (covering E. coli, Salmonella, Listeria, Campylobacter, yeasts, and moulds) that identifies microorganisms from microscopic images within seconds after incubation, reportedly achieving accuracy above 95% and producing audit-ready compliance reports with confidence scores. MicroSelect is a tri-compartment 100mm Petri dish combining TSA with 5% sheep blood, MacConkey agar, and Mannitol Salt Agar on a single plate, engineered to shorten culture time and produce images optimized for the AI analysis.

The company monetizes through a hybrid model: SaaS-style subscriptions and pay-per-test pricing ($4.99 per test, compared to $43-72 at reference labs), consumable sales of MicroSelect plates, and a freemium acquisition funnel offering 500 free analyses per month plus a 30-day free trial. Distribution combines a self-serve web portal (app.bioeureka.com) with direct enterprise sales, plus a Canadian lab-services channel for SIAL/SFCA compliance testing. Go-to-market is product-led for SMB and individual users and sales-led for enterprise and mid-market accounts, supported by trade show presence (SIAL Canada), an ROI calculator, and white-paper content marketing.

Bioeureka is private, has no disclosed revenue, and has raised approximately $1.75M in cumulative funding across five rounds from 2022 to 2024. The platform only began commercial operations in April 2025. Key strategic partners include Mila, IVADO, University of Ottawa, NRC (CNRC), Centech, Chrono Innovation, and BioLab Ottawa. The company has been recognized as an elite Canadian medtech company by AdvaMed and has received multiple regional innovation awards.

Bioeureka firmographics

Firmographics
Name
Bioeureka
Legal name
TECHNOLOGIE BIOEUREKA INC.
Website
https://bioeureka.com
Company type
Private
Founded year
2022
Operating status
Operating
Headcount range
1–10 employees
Short description
Bioeureka is a Montreal-based AI diagnostics company that provides food safety, clinical, and environmental laboratories with an AI-powered pathogen identification platform (AIMO) paired with a proprietary culture medium (MicroSelect), reducing per-test costs from $43-72 to $4.99 and turnaround times by 85%.
Ownership category
akta.pro rank

Bioeureka industry classification

Industry
Product category
AI-driven microbiological diagnostics
NAICS
Analytical Laboratory Instrument Manufacturing (334516), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHLAAAJAD
Process Analytical Technology (PAT) & In-Line/At-Line Analytics (spectroscopy, sensors, monitoring)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
SECONDARYHLAGADAH
Cell-Based & Potency Assays (Bioassays)

Keywords

  • Microbial pathogen identification
  • AI image recognition
  • Food safety testing
  • Clinical diagnostics AI
  • Microbiological consumables

Where Bioeureka is headquartered

Location

Headquarters

HQ city
Montréal
HQ country
Canada
HQ region
North America

Offices3 records

Markets served

Bioeureka business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

  1. SaaS Subscriptions (AIMO Platform): Cloud-based AI platform subscription for pathogen identification and analysis. Users pay per test or through subscription plans based on usage volume. The platform generates audit-ready reports and confidence scores.
  2. Consumables (MicroSelect): Proprietary culture medium plates sold as consumables. Designed to work exclusively with the AIMO platform, creating a hardware-software ecosystem. A laboratory analyzing 100 isolates per month can save more than $7,500 per year in consumables.
  3. Freemium/Trial Revenue Conversion: 500 free analyses per month for new users, with 30-day free trial available. Conversion from free tier to paid subscriptions represents the primary customer acquisition revenue flow.

Pricing tiers

ModelBillingPrice
FreemiumMonthlyFreemium - 500 free analyses per month
Usage-basedPay-as-you-goPay-per-test model
FreemiumMonthly30-day free trial

Go-to-market motion2 records

Distribution channels4 records

Marketing channels8 records

Bioeureka product offering

Product offering

Core offering

Bioeureka provides an AI-powered pathogen identification platform that combines the AIMO cloud software with the MicroSelect proprietary culture medium to automate microbiological detection. The solution analyzes microscopic images of bacterial colonies within minutes of incubation, delivering 95%+ accuracy, audit-ready compliance reports, and per-test costs of $4.99 versus $43–$72 for reference labs, targeting food safety, clinical diagnostics, environmental, and academic laboratories.

Product overview

Bioeureka offers a unified platform combining AI software (AIMO) with a proprietary consumable (MicroSelect) to automate microbiological detection for food safety and applied microbiology. The platform is designed to integrate seamlessly into existing laboratory workflows, requiring only a standard microscope, camera, and computer. AIMO provides AI-powered pathogen identification from microscopic images, while MicroSelect serves as the optimized culture medium that enables faster, more reliable microbial selection and better imaging results for the AI analysis.

Differentiator

Problem solved

Functional benefit

Brands

  • AIMO: AI platform for microbiological image recognition that identifies pathogens and microorganisms in seconds after incubation with accuracy above 95%, generating audit-ready compliance reports with confidence scores.
  • MicroSelect™

Products and services

  • AIMO AI-powered cloud platform dedicated to microbiological image recognition; trained on millions of images of pathogens and microorganisms, identifies colonies within seconds after incubation with accuracy above 95% and automatically generates audit-ready reports with confidence scores for food safety, clinical diagnostics, environmental testing, and academic laboratories.
  • MicroSelect Optimized tri-compartment Petri dish (100mm) combining TSA with 5% sheep blood, MacConkey agar, and Mannitol Salt Agar on a single plate; designed to work with AIMO to shorten culture time and improve image quality for AI analysis. Storage at 2–8°C with a 6-month shelf life.

Quantifiable outcome

  • Reduces cost per test from $43-72 to $4.99 (90%+ savings)
  • +6 more outcomes

Companies that use Bioeureka

Customer profile

Named customers2 records

Segments4 records

Ideal customer profiles4 records

Bioeureka technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability5 records

Feature4 records

Bioeureka partnerships and signals

Strategic signal

Partnerships

14 partnerships are on record, tiered core and minor.

  • Université d'Ottawa (University of Ottawa)coreStrategic or Co-development PartnerStrategic R&D partnership for development and validation of AI-powered pathogen detection technology. The university provides scientific expertise and laboratory facilities for testing and refining the platform.
  • Mila (Quebec AI Institute)coreStrategic or Co-development PartnerCollaboration with Mila for AI model development and deep learning expertise for pathogen identification algorithms.
  • IVADO (Institute for Data-Driven Valorization)coreStrategic or Co-development PartnerPartnership with IVADO for data science expertise and research collaboration in AI for microbiology.
  • CentechcoreStrategic or Co-development PartnerSelected for Centech Propulsion accelerator program, providing mentorship, resources, and validation support for the startup.
  • Chrono Innovation (Montreal)coreStrategic or Co-development PartnerPartnership for innovation and development activities in Montreal, contributing to platform development and testing.
  • CNRC (National Research Council Canada)coreStrategic or Co-development PartnerCollaboration with NRC for industrial technology advisory and potential regulatory pathway support.
  • Invest OttawaminorStrategic or Co-development PartnerOttawa-based innovation support organization providing resources and connections for company growth.
  • Économie et Innovation QuébecminorStrategic or Co-development PartnerQuebec government organization supporting innovation and economic development in the province.
  • BioLab OttawacoreStrategic or Co-development PartnerInitial testing and validation of the Bioeureka platform conducted at BioLab Ottawa facilities.
  • GénieLab OttawacoreStrategic or Co-development PartnerOttawa-based innovation lab contributing to technology development and validation.
  • AXEO (programme Élévation)minorChannel Partner/ Reseller/ DistributorBusiness development support through the AXEO Elevation program.
  • LaveryminorOthersQuebec law firm providing legal advisory services.
  • OSEDEAminorStrategic or Co-development PartnerTechnology partner contributing to platform development.
  • INNOVACITÉminorStrategic or Co-development PartnerInnovation ecosystem partner supporting company growth.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Bioeureka competitors and assessment

Company assessment

Direct peers

  • bioMérieux: Global leader in microbiological diagnostics and industrial microbiology. Directly comparable as it sells automated pathogen identification platforms and culture media into the same food safety, clinical and industrial testing customers that Bioeureka targets.
  • Hygiena: Specialist in rapid food safety and environmental pathogen testing, including ATP and molecular diagnostics. Closely overlaps with Bioeureka's food-safety testing focus and serves similar food processing and QA laboratories.
  • Bio-Rad Laboratories: Life science and clinical diagnostics company with strong microbiology and food safety testing offerings. Directly comparable as it sells both laboratory instruments and consumables used for pathogen identification workflows.

Broad incumbents

  • Neogen (formerly 3M Food Safety): Established food safety and animal safety diagnostics provider offering pathogen detection kits, instruments and consumables. Comparable as a broad incumbent addressing the same food-safety testing use cases with a wider product portfolio.
  • Becton, Dickinson and Company (BD): Major life sciences and diagnostics company with a large microbiology and clinical diagnostics franchise (BD MAX, BD Phoenix). Overlaps with Bioeureka in automated microbial identification and consumable culture media used in clinical labs.
  • Thermo Fisher Scientific: Global life sciences tools leader with microbiology instruments, consumables and analytical software. Broad incumbent providing competing laboratory analytical instruments and services for pathogen testing.

Emerging players

  • Specific Diagnostics: Emerging player in rapid phenotypic antimicrobial susceptibility testing and microbial identification. Comparable as an early-stage company applying novel sensing/automation to accelerate microbiology lab workflows.
  • Roka BioScience (now part of bioMérieux): Developed molecular pathogen detection assays for food safety; comparable as a focused player in rapid food pathogen testing that ultimately highlighted both the opportunity and consolidation risk in this space.
  • Clever Culture Systems (APAS Independence): Applies AI and computer vision to automated culture-plate reading in microbiology labs. Highly comparable as a niche AI-for-microbiology peer addressing the same workflow of automating pathogen identification from plate images.

Regional players

  • Mérieux NutriSciences: Food testing and certification services network with strong global but regionally anchored operations. Comparable as a service-side peer providing outsourced microbiological testing that Bioeureka's in-house platform aims to disintermediate.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Bioeureka social profiles

Digital presence

Bioeureka compliance and trust

Trust signal

Compliance3 records

Bioeureka financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Bioeureka leadership team

Management profile

Number of profiles

Profiles9 records

Bioeureka funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Bioeureka M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bioeureka

What does Bioeureka do?

Bioeureka provides an AI-powered pathogen identification platform that combines the AIMO cloud software with the MicroSelect proprietary culture medium to automate microbiological detection. The solution analyzes microscopic images of bacterial colonies within minutes of incubation, delivering 95%+ accuracy, audit-ready compliance reports, and per-test costs of $4.99 versus $43–$72 for reference labs, targeting food safety, clinical diagnostics, environmental, and academic laboratories.

Is Bioeureka a public or private company?

Bioeureka is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Bioeureka founded?

Bioeureka was founded in 2022. It employs 1 to 10 people.

Where is Bioeureka based?

Bioeureka is headquartered in Montréal, Canada, in the North America region.

How does Bioeureka make money?

Three revenue lines are on record. SaaS Subscriptions (AIMO Platform) is the primary driver. The others are consumables (MicroSelect) and freemium/Trial Revenue Conversion.

Who are Bioeureka's main competitors?

Direct peers on record are bioMérieux, Hygiena and Bio-Rad Laboratories. Broad incumbents are Neogen (formerly 3M Food Safety), Becton, Dickinson and Company (BD) and Thermo Fisher Scientific. Emerging players are Specific Diagnostics, Roka BioScience (now part of bioMérieux) and Clever Culture Systems (APAS Independence). Mérieux NutriSciences is listed as a regional player.

Does Bioeureka have an API?

No public API is recorded for Bioeureka.

What industry is Bioeureka in?

Bioeureka's product category is AI-driven microbiological diagnostics. Its primary akta.pro industry code is HLAAAJAD, Process Analytical Technology (PAT) & In-Line/At-Line Analytics (spectroscopy, sensors, monitoring), with a secondary code of HLAGADAH, Cell-Based & Potency Assays (Bioassays). Its NAICS code is 334516 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales